BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26045799)

  • 1. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
    Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of POLR1D in Colorectal Cancer.
    Tian Y; Sun F; Zhong Y; Huang W; Wang G; Liu C; Xiao Y; Wu J; Mu L
    Oncology; 2020; 98(3):138-145. PubMed ID: 31722331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
    Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
    Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
    Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
    Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.